For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sanofi ADR (NASDAQ: SNY) closed the day trading at $54.85 up 0.16% from the previous closing price of $54.76. In other words, the price has increased by $0.16 from its previous closing price. On the day, 1.43 million shares were traded. SNY stock price reached its highest trading level at $55.22 during the session, while it also had its lowest trading level at $54.8.
Ratios:
For a better understanding of SNY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.34. For the most recent quarter (mrq), Quick Ratio is recorded 0.65 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Argus on July 26, 2024, Reiterated its Buy rating but revised its target price to $60 from $55 previously.
On January 23, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $55.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNY now has a Market Capitalization of 138724425728 and an Enterprise Value of 85882142720. As of this moment, Sanofi’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.24, and their Forward P/E ratio for the next fiscal year is 11.39. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.93. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.88 while its Price-to-Book (P/B) ratio in mrq is 1.76. Its current Enterprise Value per Revenue stands at 1.824 whereas that against EBITDA is 7.307.
Stock Price History:
Over the past 52 weeks, SNY has reached a high of $58.97, while it has fallen to a 52-week low of $42.63. The 50-Day Moving Average of the stock is -1.25%, while the 200-Day Moving Average is calculated to be 8.58%.
Shares Statistics:
Over the past 3-months, SNY traded about 1.86M shares per day on average, while over the past 10 days, SNY traded about 1689680 shares per day. A total of 2.51B shares are outstanding, with a floating share count of 2.51B. Insiders hold about 0.00% of the company’s shares, while institutions hold 10.89% stake in the company. Shares short for SNY as of 1726185600 were 10762826 with a Short Ratio of 5.80, compared to 1723680000 on 11371174. Therefore, it implies a Short% of Shares Outstanding of 10762826 and a Short% of Float of 0.47999998000000005.
Dividends & Splits
SNY’s forward annual dividend rate is 2.04, up from 3.76 a year ago. Against a Trailing Annual Dividend Yield of 0.06866326The stock’s 5-year Average Dividend Yield is 3.7.
